The product cannot be regarded as a medicament of heading 3004 because it does not meet the criteria of the Additional Note 1 to Chapter 30.
Seda ei saa käsitada rubriigi 3004 ravimina, kuna see ei vasta grupi 30 lisamärkuse 1 kriteeriumidele.